October 25, 2014 12:15 PM ET

Food and Staples Retailing

Company Overview of OptumRx, Inc.

Company Overview

OptumRx, Inc., doing business as Prescription Solutions by OptumRx, provides pharmacy benefit management services. It operates a network of mail service pharmacies and community pharmacies. The company also manages prescription drug benefits of commercial, Medicare, government health plans, and employers and unions. In addition, it offers specialty pharmacy and clinical programs. The company serves managed care organizations, employers, unions/Taft Hartley trust funds, and consultants. The company was founded in 1989 and is based in Irvine, California. OptumRx, Inc. operates as a subsidiary of OptumRx Holdings, LLC.

2300 Main Street

Irvine, CA 92614

United States

Founded in 1989

Phone:

949-442-8000

Fax:

949-474-4288

Key Executives for OptumRx, Inc.

Chief Executive Officer
Age: 54
Chief Medical Officer
Chief Medical Officer and Senior Vice President
Senior Vice President of Mail Service and Specialty Operations
Compensation as of Fiscal Year 2014.

OptumRx, Inc. Key Developments

OptumRx Reports Earnings Results for the Third Quarter Ended September 30, 2014

OptumRx reported earnings results for the third quarter ended September 30, 2014. For the quarter, the company reported revenues grew 27% year-over-year to $8 billion, as third quarter script volumes increased 17% year-over-year to 142 million adjusted scripts and stronger volumes in specialty pharmaceuticals increased total revenues. Earnings from operations grew 65% to $326 million.

OptumRx Mulls Acquisitions

OptumRx, Inc. plans to make acquisitions. Dirk Mcmahon, Chief Executive Officer of OptumRx said: “Well I would say?-- I think what I'd what I would say, I go back to our local care delivery. As we think about where we're going to continue to acquire, what you'll see, as I said, four to six markets per year. We're in 21, 22 markets today. We'll ultimately, hopefully looking to grow into 75 markets in the future. And I think if you're looking for a place about where we might be looking as far as acquisitions, it would be there.”

Orexo Enters an Exclusive Reimbursement Agreement with UnitedHealth Group and OptumRx for Zubsolv

Orexo AB announced a multi-year agreement with UnitedHealth Group and OptumRx providing preferred coverage and reimbursement of ZUBSOLV. Under the agreement, ZUBSOLV will be given preferred, Tier 2 brand status on UnitedHealth Group commercial employer and individual formularies managed by OptumRx for the maintenance treatment of opioid dependence through June 30, 2014. Beginning on July 1, 2014 ZUBSOLV will become the only buprenorphine/naloxone combination product on all of UnitedHealth's closed and highly managed health plan formularies, inclusive of all brand and generic formulations.

Similar Private Companies By Industry

Company Name Region
Seald Sweet International, Inc. United States
Sales Max, Inc. United States
Affiliated Pharmacy Services United States
Reed, Inc. United States
Institutional Wholesale Co, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OptumRx, Inc., please visit www.optumrx.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.